Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

A Gluten Free Podcast

Dr Bob Anderson on Coeliac Disease Research, Immune Response & Future Treatments

20 Apr 2025

Description

A Gluten Free PodcastEpisode 176On today’s episode I chat with Associate Professor Dr Bob Anderson — a world-renowned gastroenterologist, immunologist and trailblazer in coeliac disease research. From his foundational work at the Walter and Eliza Hall Institute (WEHI) to creating Nexvax2, leading Novoviah Pharmaceuticals, and becoming President of the International Society for the Study of Coeliac Disease (ISSCD), Bob has shaped the coeliac research landscape as we know it.We discuss how his career began, what he’s most excited about in current research, and what’s ahead for coeliac disease globally — including a look at ICDS 2026 in Melbourne.What We Cover🧠 How Bob first got involved in coeliac disease research 🔬 His early work at WEHI and key discoveries 💉 The Nexvax2 vaccine – what it was designed to do and why it was discontinued 🧪 New diagnostic tools like Interleukin 2 and their future use in screening and management 🌍 Thoughts on Italy’s population screening trial and the potential for something similar in Australia 📈 How coeliac research and diagnosis has changed over the decades 🌾 Whether gluten is the issue — or environmental/lifestyle factors are at play 🌐 Why global collaboration is essential in advancing coeliac research and care 🌟 His new role as President of ISSCD and its mission 🇦🇺 What to expect from the 2026 International Coeliac Disease Symposium in Melbourne 🔭 His hopes for the future of coeliac disease researchGuest Bio: Dr Bob AndersonAssociate Professor Dr Bob Anderson is an Australian-based gastroenterologist, translational immunologist, and coeliac disease expert. He has led major research projects and pharmaceutical programs focused on immune responses to gluten and has worked closely with both the scientific community and patient groups. Bob developed Nexvax2, the first peptide-based immunotherapy for coeliac disease, and currently leads the development of T-cell diagnostics at Novoviah Pharmaceuticals. He also practises at Mackay Base Hospital and was recently named President of the International Society for the Study of Coeliac Disease (ISSCD).Links & Resources🔗 Novoviah🔬 Walter and Eliza Hall Institute of Medical Research (WEHI) 🌐 International Society for the Study of Coeliac Disease (ISSCD) 📍 ICDS 2026 – Melbourne (More info coming soon)Get Involved📩  If you want to hear about Novoviah’s upcoming coeliac disease trials, register your interest at https://novoviahtools.com. These trials are contributing to the development of new diagnostics and therapies, and not all studies will involve a gluten challenge.Connect with Us💬 DM me on Instagram: @aglutenfreefamilyHead to happytummies.com.au & use our code GFCHRISTMAS to save 20% off Free From Family Co everyday range! Valid from 8th Nov - 25th December, 2025.  Up to 25% discounts on Bask & Co products site-wide and with NO discount codes required! FREE shipping on orders over $99. Only while stocks last! Shop here🥣 Celiac Cruise - a 100% gluten free vacation cruise is setting sail on two Australian cruises in 2026: one to the South Pacific and the other to New Zealand. There'll of course be awesome 100% gluten free food onboard, heaps of fun stuff to do, educational talks and a community of people who understand each other. Buy your tickets here & see ya onboard gluten free fam! 

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.